Revvity, Inc. (NYSE:RVTY) Shares Purchased by Fisher Asset Management LLC

Fisher Asset Management LLC raised its holdings in Revvity, Inc. (NYSE:RVTY) by 41.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 57,248 shares of the company’s stock after acquiring an additional 16,633 shares during the quarter. Fisher Asset Management LLC’s holdings in Revvity were worth $6,389,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in RVTY. Gladius Capital Management LP acquired a new stake in shares of Revvity during the third quarter worth $32,000. Continuum Advisory LLC increased its stake in Revvity by 2,972.7% in the 3rd quarter. Continuum Advisory LLC now owns 338 shares of the company’s stock worth $43,000 after purchasing an additional 327 shares in the last quarter. MassMutual Private Wealth & Trust FSB raised its holdings in Revvity by 55.9% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company’s stock worth $43,000 after buying an additional 138 shares during the period. Avior Wealth Management LLC lifted its stake in Revvity by 7,980.0% during the third quarter. Avior Wealth Management LLC now owns 404 shares of the company’s stock valued at $52,000 after buying an additional 399 shares in the last quarter. Finally, Principal Securities Inc. boosted its holdings in shares of Revvity by 54.9% in the fourth quarter. Principal Securities Inc. now owns 598 shares of the company’s stock worth $67,000 after buying an additional 212 shares during the period. Institutional investors own 86.65% of the company’s stock.

Insider Buying and Selling at Revvity

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the transaction, the insider now directly owns 33,400 shares in the company, valued at $4,232,782. This trade represents a 31.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Tajinder S. Vohra sold 5,492 shares of the firm’s stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total transaction of $641,520.52. Following the completion of the transaction, the insider now directly owns 19,652 shares of the company’s stock, valued at $2,295,550.12. This represents a 21.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on RVTY shares. Sanford C. Bernstein downgraded shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price on the stock. in a research note on Friday, January 10th. Raymond James reissued an “outperform” rating and set a $145.00 price target (up from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Robert W. Baird raised their price objective on Revvity from $136.00 to $138.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 5th. Barclays upped their target price on Revvity from $135.00 to $140.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Finally, KeyCorp increased their price target on shares of Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Four investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Revvity has a consensus rating of “Moderate Buy” and an average target price of $136.25.

Revvity Trading Down 1.1 %

NYSE:RVTY opened at $109.18 on Wednesday. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. Revvity, Inc. has a 1-year low of $97.32 and a 1-year high of $129.50. The firm has a market capitalization of $13.12 billion, a price-to-earnings ratio of 49.40, a PEG ratio of 3.82 and a beta of 1.03. The business’s 50-day moving average price is $116.78 and its two-hundred day moving average price is $118.33.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period last year, the business posted $1.25 earnings per share. On average, equities analysts expect that Revvity, Inc. will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.26%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity’s dividend payout ratio (DPR) is presently 12.67%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.